KMPHARMACEUTICAL Co.,Ltd. Share Price

Equities

A225430

KR7225430008

Personal Products

End-of-day quote Korea S.E. 03:30:00 17/06/2024 am IST 5-day change 1st Jan Change
811 KRW -0.98% Intraday chart for KMPHARMACEUTICAL Co.,Ltd. -2.05% -17.08%
Dynamic Chart
Km Pharmaceutical Co., Ltd. completed the acquisition of IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction. CI
IBKS No.3 Special Purpose Acquisition Company‘s Equity Buyback announced on March 1, 2018, has expired. CI
Sungkeun Mun acquired 4.9% stake in Km Pharmaceutical Co., Ltd. from K Investment Co., Ltd., Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73, and KTB Mezzanine Private Investment Trust No. 74, funds managed by KTB Asset Management Co., Ltd for KRW 2.7 billion. CI
Km Pharmaceutical Co., Ltd. cancelled the acquisition of 4% in Iconix Co., Ltd. from Wonjung Kim, Hyunsoo Seo, Changhwan Shin, Youngsik Im and Miyoung Jung. CI
Km Pharmaceutical Co., Ltd. announces an Equity Buyback. CI
Km Pharmaceutical Co., Ltd. authorizes a Buyback Plan. CI
Km Pharmaceutical Co., Ltd. entered into an agreement to acquire IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction. CI
K Investment Co., Ltd. acquired 1% stake in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for approximately KRW 500 million. CI
Juyong Shin acquired 0.18% stake in Km Pharmaceutical Co., Ltd. from Sung Keun Mun for KRW 90.4 million. CI
Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd acquired 3.92% in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for KRW 2 billion. CI
Km Pharmaceutical Co., Ltd. signed a contract to acquire 4% in Iconix Co., Ltd. from Wonjung Kim, Hyunsoo Seo, Changhwan Shin, Youngsik Im and Miyoung Jung for KRW 4 billion. CI
ST Capital Co., Ltd and Youngin Seo acquired 0.15% stake in Km Pharmaceutical Co., Ltd from Sunggeun Moon for KRW 75 million. CI
ST Capital Co., Ltd acquired an additional 0.25% stake in Km Pharmaceutical Co., Ltd from Sunggeun Mun for approximately KRW 130 million. CI
ST Capital Co., Ltd and Youngin Seo acquired 0.74% stake in Km Pharmaceutical Co., Ltd from Sunggeun Moon for approximately KRW 380 million. CI
Sunggeun Moon sold 0.79% stake in Km Pharmaceutical Co., Ltd. for KRW 400 million. CI
More news
1 day-0.98%
1 week-2.05%
Current month+2.40%
1 month-3.22%
3 months-10.19%
6 months-18.66%
Current year-17.08%
More quotes
1 week
799.00
Extreme 799
821.00
1 month
758.00
Extreme 758
842.00
Current year
758.00
Extreme 758
1 148.00
1 year
758.00
Extreme 758
1 450.00
3 years
758.00
Extreme 758
3 200.00
5 years
758.00
Extreme 758
5 880.00
10 years
758.00
Extreme 758
6 650.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 11/18/11
Director/Board Member 40 -
Comptroller/Controller/Auditor 50 01/16/01
Members of the board TitleAgeSince
Chief Executive Officer 56 11/18/11
Corporate Officer/Principal 62 01/12/01
Director/Board Member 48 01/13/01
More insiders
KMPharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and sale of personal products. The Company is principally engaged in the manufacture and sale of oral hygiene products such as toothpaste, toothbrushes and gargles for children and adults. The Company is engaged in the manufacture and sale of beauty care products such as shampoo, body wash, cosmetics as well as other daily necessities. In addition, the Company is also engaged in the real estate leasing.
More about the company
  1. Stock Market
  2. Equities
  3. A225430 Stock